Down-regulation of stathmin expression is required for megakaryocyte maturation and platelet production

Camelia Iancu-Rubin1, David Gajzer, Joseph Tripodi

  • 1Division of Hematology and Medical Oncology, Department of Medicine, and Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY, USA. camelia.iancu-rubin@mssm.edu

Blood
|March 3, 2011
PubMed

Insights

Suppression of stathmin is crucial for megakaryocyte maturation and platelet production. Preventing stathmin down-regulation impairs cytoplasmic maturation and reduces polyploidy in megakaryocytes.

Area of Science:

  • Hematology
  • Cell Biology
  • Cytoskeleton Dynamics

Background:

  • Megakaryocyte (MK) maturation involves polyploidization and proplatelet formation, dependent on microtubule (MT) cytoskeleton dynamics.
  • The role of stathmin, an MT-regulatory protein, in MK differentiation is controversial, with conflicting findings in previous studies.

Purpose of the Study:

  • To investigate the role of stathmin in primary human MKs and resolve contradictory conclusions from prior research.
  • To determine the importance of stathmin down-regulation during megakaryocytopoiesis.

Main Methods:

  • Utilized a lentiviral-mediated gene delivery system to maintain stathmin expression in primary human MKs.
  • Assessed effects on cytoplasmic maturation markers (GPIb, PF4), ploidy levels, and overall platelet production.

Main Results:

  • Sustained stathmin expression delayed cytoplasmic maturation and reduced MK ploidy.
  • Preventing stathmin down-regulation significantly impaired platelet production.
  • Demonstrated that stathmin suppression is essential for normal MK maturation.

Conclusions:

  • Stathmin down-regulation is biologically important for effective MK maturation and platelet production.
  • Microtubule regulation, specifically stathmin suppression, is critical during the final stages of thrombopoiesis.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...